Dialyser Reuse and Reprocessing
On this page
Direct answer
Dialyser reprocessing rinses, cleans, disinfects and tests a used hollow-fibre dialyser so the same patient can use it again: after dialysis the blood compartment is reverse-rinsed with treated water, protein and clot deposits are cleaned with agents such as sodium hypochlorite and peracetic acid, the device is sterilised (commonly formaldehyde 2-4 per cent or peracetic-acid-based sterilants), and it is stored until the next session. Before reuse it must pass a leak test and retain at least 80 per cent of its original total cell volume (TCV), with residual germicide verified negative after rinsing. Indian units reprocess routinely — commonly five to six reuses per dialyser, subject to hospital policy and TCV — because it cuts consumable cost substantially.
What you must remember
- Steps in order: rinse (reverse ultrafiltration with water), cleaning (chemical), performance testing (TCV, leak and pressure tests), sterilisation/disinfection, labelling, controlled storage, and pre-use rinsing with residual-germicide testing.
- TCV rule: a dialyser is condemned when its total cell volume falls below 80 per cent of the original — the objective, measurable endpoint that stops reuse beyond clearance benefit.
- Germicides: formaldehyde 2-4 per cent (cheap, irritant, anti-N-formaldehyde antibody risk from inadequate rinsing) and peracetic-acid-based sterilants at manufacturer-specified strength (rapidly sporicidal, decomposes to acetic acid and oxygen).
- Cleaning agents: sodium hypochlorite for blood proteins on the fibre surface, peracetic acid or hydrogen peroxide alternatives; heat-citric methods suit some synthetic high-flux dialysers.
- Labelling is non-negotiable: patient name and ID, reuse number, date, and reprocessor initials — a mislabelled dialyser is a patient-safety incident, not a clerical slip.
- Contraindications to reuse: hepatitis B and HIV-positive patients in most Indian policies, along with any reuse prohibited by unit protocol; each dialyser stays patient-specific throughout.
- Complications to recognise: pyrogenic reactions from contaminated reprocessing water, chemical injury from residual sterilant (formaldehyde — burning pain along the access; chloramine-like haemolysis from hypochlorite residue), and the gradual clearance loss tracked by TCV.
Life of a reused dialyser
Follow one high-flux dialyser through a week. Monday it runs four hours on patient A, anticoagulated adequately, and comes off with amber fibres. In the reprocessing room it is hung blood-port-down and reverse-rinsed with RO water until the effluent runs clear; the automated reprocessor then cycles cleaning chemical through, measures the total cell volume by filling the fibres and pressurising — 82 millilitres against an original 96, so 85 per cent, passed — pressure-tests the header for leaks, floods the compartments with peracetic sterilant, caps it, labels it "Patient A, reuse 3", and shelves it in the disinfected storage area. Before Thursday's session the dialyser is rinsed per protocol and the effluent is tested for residual peracetic acid with a test strip: negative, machine primed, patient connected.
The drama hides in two places. If the TCV had read 74 millilitres — below the 80 per cent line — the dialyser is discarded however clean it looks, because fibre clots mean lost surface and a Kt/V the prescription did not bargain for. And if the rinse had been skimped, residual formaldehyde meets the patient's blood within the first minutes: access-arm burning, chest tightness, and, with repeated exposure, the historical anti-N-formaldehyde antibody problem that caused haemolysis and transfusion dependence — the reason residual testing became mandatory.
Where Indian units differ
Under the Pradhan Mantri National Dialysis Programme and state models where per-treatment reimbursement is tight, reuse is standard economics, not an exception — high-flux dialysers reprocessed five to ten times in some units, always within TCV limits. The examinable Indian realities: reuse is generally not performed for HBsAg-positive patients; the reprocessing area must be separate, ventilated and PPE-staffed because formaldehyde is a sensitizer; and reprocessing water must itself meet AAMI standards, since contaminated rinses have caused pyrogenic outbreaks. A viva question "how do you decide a dialyser is unfit for reuse?" has one objective answer — TCV below 80 per cent — and everything else (visible clotting, header cracks, failed leak test) is secondary.
Frequently asked questions
What is the total cell volume criterion for discarding a reused dialyser?
A TCV below 80 per cent of the original measured value condemns the dialyser, because lost fibre volume means lost clearance.
Which sterilants are used in dialyser reprocessing?
Formaldehyde 2-4 per cent and peracetic-acid-based cold sterilants at manufacturer-specified concentrations, each requiring verified rinsing and residual testing before reuse.
Why is dialyser reuse usually avoided in hepatitis B-positive patients?
Reprocessing policies commonly exclude such patients to eliminate any risk of cross-contamination and machine-to-patient linkage in an isolation-setting dialysis unit.
What complication follows inadequate rinsing of formaldehyde?
Immediate access-arm and chest burning from chemical irritation, and with repeated exposure, anti-N-formaldehyde antibodies causing haemolysis — hence mandatory residual testing.
How does reuse affect dialysis dose?
Each reuse cycle costs some fibre patency; clearance declines as TCV falls, so adequacy (Kt/V) must be audited while reuse numbers rise, and the dialyser discarded at the 80 per cent cutoff.